Skip to content
Search

Latest Stories

SPECIAL FEATURE: How stress at work drove a locum out of pharmacy

Pharmacists are like ducks on the pond – smooth and calm on top but paddling relentlessly underneath, says Ashni.

After over 15 years in the profession, and working mostly as a locum pharmacist, Ashni felt he could no longer keep going – he needed a change.


The trigger for Ashni was when shockwaves ran through the pharmacy sector in December 2015.

He recalls how the announcement of funding cuts caught everyone flat footed and sent all sorts of mixed signals, especially amongst pharmacy professionals.

Ashni, who used to manage a community pharmacy as a locum at the time, felt the government “wanted to get rid of community pharmacies.” Speculations were also rife that up to “a quarter of them would be gone” in no time.

He explained how “they also talked about further funding cuts in the near future,” which made pharmacy contractors incredibly worried; they knew they needed to make hard business decisions for survival.

“And eventually it all cascaded down to locum pharmacists like me.

“I felt I was actually drowning in pharmacy because of the ever rising targets – you are up against the contract, doctors, wholesalers, patients and an owner concerned mainly about profitability. It made me feel like a punching bag and a doormat.”

Ashni chose the profession because he was very passionate about healthcare and “helping my patients.”

“But I could no longer give even half a decent service to my patients because of added workload. Staff were taken away and more was expected of the pharmacist in terms of targets and new service offerings. How could one cope?”

“It felt as though I was being set up to fail in my professional capacity due to the ever-increasing demands in the profession. I woke up in the morning dreading work.”

He recounts a lot of other issues such as the volumes of paperwork that a pharmacist needed to carry out on a daily basis, the demands from local bodies, shortages of medicines and devices like inhalers and having to send anonymized scripts to the distributors to obtain precious stock.

“Within my time in pharmacy I felt as though I de-skilled myself completely.” For Ashni, dealing with MURs was more clerical as everything was rushed through to get the patient’s signature, and it was the responsibility of the pharmacist to ensure that everything was in order for any surprise inspections from the pharmacy regulators.

“Contractors worked out that they would have to find ways of managing with less income in order to stay viable. And consequently, locum rates fell sharply, staff were continually trimmed down, but the work volume just kept piling up.

“There was always this constant pressure to perform, meet targets and expectations – all dressed up to make everyone else feel good.”

Ashni decided that unlike his pharmacy colleagues, he couldn’t carry on paddling at that rate.

Realising he needed to switch gears, he started looking for options and trained to become a driving instructor. After qualifying as one in 2018, he continued to work for up to three days as a locum, whilst also testing himself out behind the wheels during the rest of the week.

Has anything changed since his latest career move?

“A lot!” said Ashni, emphatically, adding: “I have never been so happy. I sleep so much better. My eyesight has improved. I don’t get short-tempered or snappy anymore.”

He says he now feels much fitter, happier and more stress-free.

“But I didn’t fully understand the mental impact of the stress and strain until I left pharmacy completely.”

This article also appears in the February issue of Pharmacy Business.

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less